A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia

Documents similaires

• Acquired thiopurine resistance and mismatch repair aberrations in paediatric B‐cell acute lymphoblastic leukaemia relapse: A real‐world data integrating mutational signatures, clones and clinical thiopurine dosing patterns
  par: Prateek Bhatia, et autres
  Publié: (2026)
• CD48 Is a Robust Marker and a Useful Addition for Assessment of Measurable Residual Disease in T‐Cell Acute Lymphoblastic Leukemia
  par: Tharageswari Srinivasan, et autres
  Publié: (2025)
• Comprehensive Cytopathologic, Flow Cytometric and Immunocytochemical Analysis of a Challenging Case of Small Cell Variant of Anaplastic Large T‐Cell Lymphoma in a Child
  par: Bhawana Dhiman, et autres
  Publié: (2025)
• Comparative Analysis of 12 Flow Cytometry‐Based Markers in B‐Lymphoblastic Leukemia/Lymphoma and Their Utility in Detecting Minimal/Measurable Residual Disease
  par: Tharageswari Srinivasan, et autres
  Publié: (2025)
• Comment on: A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia
  par: Donát Alpár, et autres
  Publié: (2025)